Carlyle ends boardroom spat at India's Metropolis

The US private equity firm's purchase of a stake in the pathology laboratories chain signals an end to a boardroom battle triggered by Warburg Pincus' exit earlier this year.

The Carlyle Group said on Wednesday it had acquired a stake in Metropolis Healthcare, a chain of pathology laboratories in India, signaling an end to a boardroom battle between the founders. 

Rival private equity firm Warburg Pincus sold its 27% stake in Metropolis in April to the Shah family which triggered a change of control and the end of a long-running power struggle between the founders, Sushil Shah and GSK Velu. 

The Shah family used financing from KKR to complete the purchase. Carlyle is acquiring the stake held by Velu and his affiliates. Financial details were not disclosed.

India has become a...

¬ Haymarket Media Limited. All rights reserved.

FinanceAsia has updated its subscription model.

Registered readers now have the opportunity to read 5 articles from our award-winning website for free.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences.

To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222

Article limit is reached.

Hello! You have used up all of your free articles on FinanceAsia.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences. To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222